Trademark: 79345490
Status Date
Tuesday, November 21, 2023
Registration Number
7220558
Registration Date
Tuesday, November 21, 2023
Filing Date
Thursday, January 13, 2022
Published for Opposition
Tuesday, September 5, 2023
40 Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacture of therapeutic solutions, namely, antigens, antibodies, T cells
5 pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for the treatment of cancer and tumors; biological and pharmaceutical preparations for cancer and tumor treatment using immunotherapy; therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical products for medical use for the treatment of cancer and tumors; diagnostic preparations for medical purposes, namely, antigens, antibodies, cells for therapeutic use
1 biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions
44 providing medical information with regard to immunotherapy
42 Scientific research services for medical purposes; scientific research and product development, namely, antigen identification, screening and development services; scientific and technological research services in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information with regard to immunotherapy; scientific research and development, namely, providing services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific research, namely, epigenetic antigen screening and identification services for therapeutic research purposes; medical research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; providing medical and scientific research information, namely, designing algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform for use in forecasting the characteristics of antigens and immunological responses through the use of algorithms
Mar 18, 2024
Final Decision Transaction Processed By Ib
Feb 22, 2024
Final Disposition Notice Sent To Ib
Feb 22, 2024
Final Disposition Processed
Feb 21, 2024
Final Disposition Notice Created, To Be Sent To Ib
Nov 21, 2023
Notice Of Registration Confirmation Emailed
Nov 21, 2023
Registered-Principal Register
Sep 5, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 5, 2023
Published For Opposition
Sep 4, 2023
Notification Processed By Ib
Aug 16, 2023
Notification Of Possible Opposition Sent To Ib
Aug 16, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 16, 2023
Notification Of Notice Of Publication E-Mailed
Aug 2, 2023
Approved For Pub - Principal Register
Aug 2, 2023
Examiner's Amendment Entered
Aug 2, 2023
Notification Of Examiners Amendment E-Mailed
Aug 2, 2023
Examiners Amendment E-Mailed
Aug 2, 2023
Examiners Amendment -Written
Jul 7, 2023
Teas Change Of Correspondence Received
Jul 7, 2023
Teas Change Of Domestic Representatives Address
Jul 7, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 7, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 6, 2023
Teas/Email Correspondence Entered
Jul 6, 2023
Correspondence Received In Law Office
Jul 6, 2023
Teas Response To Office Action Received
Feb 2, 2023
Refusal Processed By Ib
Jan 9, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jan 8, 2023
Refusal Processed By Mpu
Oct 26, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Oct 25, 2022
Non-Final Action Written
Oct 21, 2022
Assigned To Examiner
Jul 26, 2022
Application Filing Receipt Mailed
Jul 22, 2022
New Application Office Supplied Data Entered
Jul 21, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
